acetylleucine mylan

!"##$%&&'''()*+#,--,.*(/0&.1),+2.13#456789::7;6<=74>9:5=("#.?
ACETYLLEUCINE*MYLAN*
Traitement*symptomatique*de*la*crise*vertigineuse.*
pathologies*pour*lesquelles*il*peut@être*prescrit*
@?60,-1?A10#,B,31C-1??
?
6D2--1?#"E02$1C#,FC1?
=1C0*D*B,14$-G+",2#0,1??
H0,3+,$1-?2+#,/-?
5+E#GDD1C+,31??
7I+,$,13#-?
5.,)*3?)1?.2J-K??62D+,C.?+20L*32#1K??>2B3E-,C.?-#E202#1?
M7NOPQ??
R#2#C#?
61?.E),+2.13#?1-#?=S=?RS;><R?5?HT7R6T<H8<S=?>7U<65:7??
H0,I?)1?A13#1?886?
VKPN?W?
8I?)1?01.L*C0-1.13#?
RR?
XY?Z?
:2L*02#*,01?
>GD23??
?
?
H0E-13#2#,*3?H0E+2C#,*3-?[0*--1--1?1#?2DD2,#1.13#?7//1#-?,3)E-,02LD1-??
Posologie*:*Chez*l'adulte*
\KN?]?P?B?$20?^*C0K?-*,#?X?]?V?+*.$0,.E-?$20?^*C0K?13?)1CI?$0,-1-?.2#,3?1#?-*,0(?
:2?)C0E1?)C?#02,#1.13#?1-#?A20,2LD1?-1D*3?D_EA*DC#,*3?+D,3,FC1?M13#01?\Y?^*C0-?1#?N?]?`?
-1.2,31-Qa?2C?)ELC#?)C?#02,#1.13#?*C?13?+2-?)_,3-C++b-K?D2?$*-*D*B,1?$1C#?c#01?
2CB.13#E1?-23-?,3+*3AE3,13#?^C-FC_]?X?B?1#?.c.1?V?B?$20?^*C0(?
Mode*d'administration?%?d*,1?*02D1(?
5spect*et*forme*:*6*.$0,.E?LD23+K?L,+*3A1I1?1#?)1?/*0.1?2DD*3BE1(?
Classe*pharmacothérapeutique*:**
ANTIVERTIGINEUX*DE*MÉCANISME*D'ACTION*INCONNU?
6*)1?586?%?N07CA04.?